Status:
UNKNOWN
Vitamin C, Vitamin B1 and Steroid in Sepsis
Lead Sponsor:
Far Eastern Memorial Hospital
Conditions:
Sepsis, Severe
Eligibility:
All Genders
20+ years
Phase:
PHASE4
Brief Summary
A randomized controlled trial to test the synergic modulation effect of vitamin C, thiamine and hydrocortisone in patients with severe sepsis or septic shock.
Detailed Description
Management of sepsis bases on three components: infection control, haemodynamic stabilization and modulation of the septic response. Many clinical trials conducted agents to block the inflammatory cas...
Eligibility Criteria
Inclusion
- aged equal or over 20
- admitted to MICU due to severe sepsis or septic shock
Exclusion
- Patients who are pregnant
- known history of Vitamin C , Vitamin B or hydrocortisone (or other equivalent products) allergy
Key Trial Info
Start Date :
December 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04039815
Start Date
December 3 2019
End Date
December 31 2020
Last Update
December 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Far Eastern Memorial Hospital
Taipei County, Taiwan, 100